The Lead Episode 27: A Discussion of Utility and Limitations of Ablation Index for Guiding Therapy in Ventricular Myocardium

Description

The Ablation Index (AI) has limited value for guiding ablation in ventricular myocardium, particularly scar. This may be related to small proportional significance of application duration and complex tissue architecture.

Learning Objectives

To understand the utility and limitations of ablation index for guiding ablation therapy in ventricular myocardium.

Article Authors and Podcast Contributors

Article Authors
Arwa Younis, MD, Israel Zilberman, DVM, Hagai Yavin, MD, Koji Higuchi, MD, Michael Barkagan, MD, Elad Anter, MD

Podcast Contributors
Joshua D. Moss, MD, FHRS, of University of California, San Francisco
Thomas A Dewland, MD, FHRS, of University of California, San Francisco
Nathaniel Steiger, MD, of Brigham and Women's Hospital

Disclosures

All relevant financial relationships have been mitigated.

Host Disclosure(s):
J. Moss: Honoraria/Speaking/Consulting Fee: Biosense Webster, Farapulse, Haemonetics, Baylis Medical, Abbott; Stocks (Publicly Traded): Doximity, Moderna Therapeutics

Contributor Disclosure(s):
T. Dewland: Honoraria/Speaking/Consulting Fee: Adagio Medical
N. Steiger: No relevant financial relationships with ineligible companies to disclose.

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose.
S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Summary

Availability:

On-Demand

Cost:

FREE

Credit Offered:

No Credit Offered